Targeting the invasive capability of cancer is a promising strategy for treatment. Therapies aimed at inhibiting MMPs, blocking EMT, or strengthening cell adhesion can potentially reduce the spread of cancer. Additionally, immunotherapies that enhance the bodyâs immune response against invasive cancer cells are being explored. However, the complexity of cancer invasion poses significant challenges in developing effective treatments.
